•
Jun 30, 2020

Voyager Therapeutics Q2 2020 Earnings Report

Total Revenue
$28.7M
Previous year: $46.1M
-37.8%
EPS
-$0.23
Previous year: $0.29
-179.3%
Gross Profit
-$742K
Previous year: $20.8M
-103.6%
Cash and Equivalents
$144M
Previous year: $79.9M
+80.7%
Free Cash Flow
-$23.1M
Previous year: -$33.6M
-31.3%
Total Assets
$297M
Previous year: $389M
-23.5%

Voyager Therapeutics

Voyager Therapeutics